Drugs for Spondyloarthropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 165)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Pamidronic acid |
Approved |
Phase 4 |
|
40391-99-9 |
4674 |
Synonyms:
(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-Amino-1-hydroxypropylidene)-1,1-bisphosphonate
1 Hydroxy 3 aminopropane 1,1 diphosphonic acid
1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
ACIDE PAMIDRONIQUE
Acide pamidronique [INN-French]
ACIDO PAMIDRONICO
Acido pamidronico [INN-Spanish]
ACIDUM PAMIDRONICUM
Acidum pamidronicum [INN-Latin]
AHPrBP
Amidronate
Amino 1 hydroxypropane 1,1 diphosphonate
Amino-1-hydroxypropane-1,1-diphosphonate
Aminohydroxypropylidene diphosphonate
|
Aminomux
Aminopropanehydroxydiphosphonate
APD
ARD233
Aredia
Aredia®|CGP-23339AE|disodium pamidronate
CGP-23339AE
Novartis brand OF pamidronate disodium salt
PAMIDRONATE
Pamidronate calcium
Pamidronate disodium
Pamidronate monosodium
Pamidronic acid
Ribodroat
|
|
2 |
|
Etoricoxib |
Approved, Investigational |
Phase 4 |
|
202409-33-4 |
123619 |
Synonyms:
5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulphonyl)phenyl)pyridine
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-3-(4-methanesulphonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-Chloro-6'-methyl-3-(p-(methylsulphonyl)phenyl)-2,3'-bipyridine
Arcoxia
Arcoxia®|MK 0663|MK-0663|MK0663
|
ETORICOXIB
étoricoxib
Etoricoxibum
L791456
L-791456
MK 0663
MK-0663
MK-663
|
|
3 |
|
Triamcinolone |
Approved, Vet_approved |
Phase 4 |
|
124-94-7 |
31307 |
Synonyms:
11b,16a,17a,21-Tetrahydroxy-9a-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
11Β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
9a-Fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9a-Fluoro-11b,16a,17a,21-tetrahydroxypregna-1,4-diene-3,20-dione
9a-Fluoro-16a-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9-Fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9Α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9Α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9Α-fluoro-16α-hydroxyprednisolone
Adcortyl
Aristocort
ARISTOCORT A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
Celeste
Cinolone
Cinolone-T
DELPHICORT
Fluoxiprednisolone
fluoxiprednisolone|Kenalog®|Nasacort®
Fluoxyprednisolone
Flutex
Fougera
Kenacort
Kenacort-A
Kenacort-Ag
KENALOG
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
Ledercort
|
NASACORT
Nasacort Aq
Nasacort Hfa
NSC-13397
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Rodinolone
Sk-Triamcinolone
TIAMCINOLONUM
Tiamcinolonum [INN-Latin]
Triacet
Triacort
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
TRIAMCINOLONE
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triam-Tablinen
Triatex
Tricortale
Triderm
Trilone
Tri-Nasal
Tristoject
Trymex
Vetalog
Volon
Volon A
|
|
4 |
|
Hydroxychloroquine |
Approved |
Phase 4 |
|
118-42-3 |
3652 |
Synonyms:
(+-)-Hydroxychloroquine
(±)-HYDROXYCHLOROQUINE
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
Axemal
DOLQUINE
Dolquine®|Plaquenil®
Ercoquin
Gen-Hydroxychloroquine 200mg Tablets
HCQ
Hidroxicloroquina
|
Hidroxicloroquina [inn-spanish]
Hydroxychlorochin
Hydroxychloroguine
HYDROXYCHLOROQUINE
Hydroxychloroquine sulfate
Hydroxychloroquine sulfate (1:1) salt
Hydroxychloroquinum
Hydroxychloroquinum [inn-latin]
Idrossiclorochina [dcit]
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
Plaquenil
Polirreumin
Quensyl
|
|
5 |
|
Loxoprofen |
Approved |
Phase 4 |
|
80382-23-6, 68767-14-6 |
3965 |
Synonyms:
(+-)-((2-Oxocyclopentyl)methyl)hydratropate
(+-)-((2-Oxocyclopentyl)methyl)hydratropic acid
2-(4-((2-Oxocyclopentyl)methyl)phenyl)propionic acid
2-OCPPP
Loxoprofen
Loxoprofen alcohol
Loxoprofen sodium dihydrate
|
Loxoprofen sodium hydrate
Loxoprofen sodium, (r*,s*)-isomer
Loxoprofene
Loxoprofeno
Loxoprofenum
Sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate dihydrate
Sodium loxoprofen
|
|
6 |
|
Aceclofenac |
Approved, Investigational |
Phase 4 |
|
89796-99-6 |
71771 |
Synonyms:
2-((2,6-Dichlorophenyl)amino)phenylacetoxyacetic acid
2-[(2,6-Dichlorophenyl)amino]benzeneacetate carboxymethyl ester
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid carboxymethyl ester
2-[(2,6-Dichlorophenyl)amino]phenylacetoxyacetate
2-[(2',6'-Dichlorophenyl)amino]phenylacetoxyacetate
2-[(2,6-Dichlorophenyl)amino]phenylacetoxyacetic acid
2-[(2',6'-Dichlorophenyl)amino]phenylacetoxyacetic acid
ACECLOFENAC
Acéclofénac
ACECLOFENAC BETADEX
Aceclofenaco
Aceclofenacum
Airtal
Airtal difucrem
Aital
Beofenac
|
Biofenac
Bristaflam
Cincofen
Clanza
Clanza CR
Falcol
Falcol difucrem
Gerbin
Gerbin difucrem
Glycolate [O-(2,6-dichloroanilino)phenyl]acetate ester
Glycolic acid [O-(2,6-dichloroanilino)phenyl]acetate ester
Glycolic acid [O-(2,6-dichloroanilino)phenyl]acetic acid ester
Hifenac
PR-82/3
Preservex
Sanein
|
|
7 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
8 |
|
Golimumab |
Approved |
Phase 4 |
|
476181-74-5 |
|
Synonyms:
|
9 |
|
Tofacitinib |
Approved, Investigational |
Phase 4 |
|
477600-75-2 |
9926791 |
Synonyms:
550
CP- 690 550
CP 690550
CP-690
CP690,550
CP-690,550
CP-690,550 FREE BASE
CP-690,550|CP-690550|tasocitinib|Xeljanz®
|
CP690550
CP-690550
CP-690-550
CP-690550 FREE BASE
TASOCITINIB
TOFACITINIB
Tofacitinibum
XELJANZ
|
|
10 |
|
Certolizumab pegol |
Approved |
Phase 4 |
|
428863-50-7 |
|
Synonyms:
|
CERTOLIZUMAB PEGOL
CIMZIA
PHA-738144
|
|
11 |
|
Etanercept |
Approved, Investigational |
Phase 4 |
|
185243-69-0 |
|
Synonyms:
BENEPALI
CD120B
ENBREL
Enbrel Sureclick
Etanercept
etanercept-szzs
etanercept-ykro
FC
GP2015
GP-2015
GP2015C
HD203
L04AB01
|
LBEC0101
P75
P80 TNF-ALPHA RECEPTOR
Recombinant human TNF
RHU TNFR
rhu TNFR:Fc
rhu-TNFR:Fc
TNF-R2
TNFR-Immunoadhesin
TUMOR NECROSIS FACTOR RECEPTOR 2
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B PRECURSOR
TUMOR NECROSIS FACTOR RECEPTOR TYPE II
|
|
12 |
|
Celecoxib |
Approved, Investigational |
Phase 4 |
|
169590-42-5 |
2662 |
Synonyms:
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENE-1-SULFONAMIDE
4-[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL)-1H-PYRAZOL-YL]BENZENESULFONAMIDE
CELEBRA
Celebrex
CELECOX
Celecox®|Elyxyb® (DFN-15; oral solution)|Onsenal®|SC-58635|SC58635
Celecoxib
Célécoxib
|
Celecoxibum
Celocoxib
DFN15
DFN-15
Onsenal
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulphonamide
SC-58635
|
|
13 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4 |
|
15307-86-5, 15307-79-6 |
3033 |
Synonyms:
[2-(2,6-Dichloroanilino)phenyl]acetate
[2-(2,6-Dichloroanilino)phenyl]acetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-[(2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
ACOFLAM
ACOFLAM RET
ACOFLAM SR
Allvoran
Apo-Diclo
ARTHRONAC
ARTHROTEC
ARTHROTEC 50
ARTHROTEC 75
Assaren
Benfofen
CAMBIA
CAT458
CATAFLAM
Cataflam®|CGP-45840B|GP-45840|Voltaren®|Voltarol®
CGP-45840B
CLOSTERIL 100
DEFANAC
DEFANAC RETARD
DEFANAC SR
Delphimix
DEXOMON RET
DEXOMON SR
Dichlofenac
Dichlofenal
Dichronic
Diclobenin
Diclofenac
Diclofenac acid
Diclofenac potassium
DICLOFENAC SOD
Diclofenac sodium
DICLOFENAC SODIUM SALT
Diclofenac, sodium
Diclofenaco
Diclofenacum
Diclofenamate
Diclofenamic acid
DICLOFLEX
DICLOFLEX RET
DICLOFLEX SR
DICLOMAX RET
DICLOMAX SR
Diclonate p
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
DICLOTARD 100 MR
DICLOTARD 75 MR
DICLOVOL
DICLOVOL RET
DICLOVOL SR
DICLOZIP 25
DICLOZIP 50
Dicrofenac
DIFENOR XL
DIGENAC XL 100
Dolobasan
DSG318
Duravolten
DYLOJECT
Ecofenac
ECONAC
ECONAC SR
ECONAC XL
Effekton
ENSTAR SR
ENSTAR XL
ENZED
Feloran
FENACTOL
FENACTOL RET
|
FENACTOL SR
FLAMATAK MR
FLAMRASE
FLAMRASE SR
FLEXOTARD MR
GP-45840
ISCLOFEN
ISV-205
Kriplex
LOFENSAID 25
LOFENSAID 50
LOFENSAID RET 100
LOFENSAID RET 75
MASIDEMEN
MISOFEN
MOBIGEL
MOBIGEL PAINEZE
MOTIFENE
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Orthofen
Orthophen
Ortofen
PENNSAID
Primofenac
Prophenatin
ProSorb-D
RHEUMATAC RET 75
RHUMALGAN
RHUMALGAN CR 100
RHUMALGAN CR 75
RHUMALGAN SR
RHUMALGAN XL
SLOFENAC
Sodium diclofenac
Solaraze
Solaraze T
SR 38
SR-38
Tsudohmin
VALDIC 100 RET
VALDIC 75 RET
VALENAC
Valetan
VOL458
Voldal
VOLRAMAN
VOLSAID RET 100
VOLSAID RET 75
Voltaren
VOLTAREN EMULGEL
Voltaren Ophtha
VOLTAREN OPHTHALMIC
Voltaren Rapide
VOLTAREN RET
Voltaren SR
VOLTAREN XR
VOLTARENE
VOLTARENE EMULGEL
VOLTARENE L.P.
VOLTARENE RET
VOLTAREN-XR
Voltarol
VOLTAROL 12 HOUR EMULGEL P
VOLTAROL ACTIVE
VOLTAROL EMULGEL
VOLTAROL EMULGEL P
VOLTAROL GEL PATCH
VOLTAROL OPHTHA
VOLTAROL PAIN-EZE EMULGEL
VOLTAROL RET
VOLTAROL SR
Xenid
Zorvolex
ZORVOLEX CAPSULES
|
|
14 |
|
Meloxicam |
Approved, Vet_approved |
Phase 4 |
|
71125-38-7 |
54677470 5281106 |
Synonyms:
Apo-meloxicam
Co Meloxicam
Dom-meloxicam
Gen-meloxicam
Masflex
Meloxicam
Méloxicam
Meloxicamum
Meloxicamum [latin]
Metacam
Miloxicam
Mobec
Mobic
Mobic®|UHAC-62XX
Mobicox
Movalis
Movatec
|
Movicox
N1539
N-1539
Novo-meloxicam
Parocin
PHL-meloxicam
PMS-meloxicam
QMIIZ ODT
Ratio-meloxicam
Reumoxicam
Tenaron
UH-AC 62XX
UH-AC-62 XX
UHAC-62XX
UNII-VG2QF83CGL
Uticox
VIVLODEX
|
|
15 |
|
Acetaminophen |
Approved |
Phase 4 |
|
103-90-2 |
1983 |
Synonyms:
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4'-Hydroxyacetanilide
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
A.F. anacin
ABDINE
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-tap
Acenol
Acephen
Acertol
Aceta elixir
Aceta tablets
Acetaco
Acetagesic
Acetalgin
Acetamidophenol
Acetaminofen
ACETAMINOFÉN
ACETAMINOPHEN
Acetaminophen uniserts
acetaminophen|Panadol®|Tylenol®
Acetaminophene
ACÉTAMINOPHÈNE
Acetamol
Acetofen
Acetominophen
Actamin
Actamin extra
Actamin super
Actifed plus
Actimol
Actimol chewable tablets
Actimol children's suspension
Actimol infants' suspension
Actimol junior strength caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
alpha-Per
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen max
Anacin
Anacin 3
Anacin3
Anacin-3
Anacin-3 extra strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
ANGIERS
Anhiba
Anoquan
Anti-algos
Antidol
Apacet
Apacet capsules
Apacet elixir
Apacet extra strength caplets
Apacet extra strength tablets
Apacet regular strength tablets
Apadon
Apamid
Apamide
APAP
a-Per
Apitrelal
Apo-acetaminophen
Arfen
Asetam
Asomal
Aspac
Aspirin free anacin maximum strength caplets
Aspirin free anacin maximum strength gel caplets
Aspirin free anacin maximum strength tablets
Aspirin-free anacin
Aspirin-free excedrin caplets
Asplin
Atasol
Atasol caplets
Atasol drops
Atasol forte caplets
Atasol forte tablets
Atasol oral solution
Atasol tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap HC
Banesin
Bayer Select
Bayer select allergy-sinus
Bayer select head cold
Bayer select headache pain
Bayer select maximum strength headache pain relief formula
Bayer select menstrual multi-symptom
Bayer select sinus pain relief
Benmyo
Ben-u-ron
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
Cadafen
Calapol
Calmanticold
Calpol
CALPOL SIX PLUS
CALPOL SIX PLUS FASTMELTS
Capital with codeine
Captin
Causalon
Cefalex
Cetadol
CHILD LEMSIP
Children'S acetaminophen elixir drops
Children'S acetaminophen oral solution
Children'S tylenol chewable
Claradol codeine
Clixodyne
Codabrol
COD-Acamol forte
Codalgin
Codapane
Codicet
Codisal
Codisal forte
Codoliprane
Codral pain relief
Cofamol
CO-Gesic
Conacetol
Contac cough & sore throat formula
Contra-schmerz p
Coricidin
Coricidin D
Coricidin sinus
Cosutone
Croix blanche
CUPANOL
Cuponol
Curadon
Curpol
Custodial
DAFALGAN
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril extra-strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
DHC Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
DISPROL INFANT
DISPROL JNR
DISPROL PAED
Dolcor
Dolefin
Dolegrippin
Dolene ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol forte
Dolorstop
Dolotec
Dolprone
Dol-stop
Dorocoff
Dresan
Dristan cold no drowsiness
Dristancito
Drixoral Plus
Dularin
Duracetamol
Duradyne DHC
Durapan
Dymadon
Dymadon co
Dymadon forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-plus
Eu-med
Excedrin
Excedrin caplets
Excedrin extra strength caplets
Excipain
Exdol
Exdol strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-gesic
Febrolin
Femcet
Fendon
FENNINGS
Fensum
Fepanil
Feverall
Feverall junior strength
Feverall sprinkle caps junior strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon p
Freka-cetamol
GALPAMOL
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap children's elixir
Genapap children's tablets
Genapap extra strength caplets
Genapap extra strength tablets
Genapap regular strength tablets
Genebs
Genebs extra strength caplets
Genebs regular strength tablets
Genebs X-tra
Geralgine-p
Gripin bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hycomine compound
Hydrocet
Hydroxyacetanilide
Hy-phen
Ildamol
Inalgex
Infadrops
Infants' feverall
Influbene N
Injectapap
Intensin
Janupap
Junior disprol
JUNIOR PARAPAED
Kataprin
Kinder finimal
Korum
Kratofin simplex
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liquagesic
Liquigesic co
Liquiprin
Liquiprin children's elixir
Liquiprin infants" drops
Lonarid
Lonarid mono
Lorcet-HD
Lortab
Lupocet
Lyteca
Lyteca syrup
Magnidol
Malex N
Malgis
Malidens
MANDANOL
Maxadol
Medigesic plus
MEDINOL
MEDINOL FOR CHILDREN
MEDINOL OVER 6
Medinol paediatric
MEDINOL UNDER 6
MEDISED PLAIN
Medocodene
Melabon infantil
Mexalen
Midol maximum strength
Midol PM night time formula
Midol regular strength
Midol teen formula
Migraleve yellow
Minafen
Minoset
MIRADOL
Miralgin
Momentum
|
mono Praecimed
Multin
N-(4-Hydroxyphenyl)acetamide
N-(4-Hydroxyphenyl)acetanilide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
Naldegesic
NAPA
Napafen
Napap
Naprinol
Nealgyl
Nebs
NeoCitran
Neodol
Neodolito
Neo-fepramol
Neopap
Neotrend
Neuridon
New cortal for children
NilnOcen
Nina
Nobedon
Nodolex
NO-Febril
Noral
Norcet
Norco
NSC-109028
NSC-3991
O-Acetaminophenol
OFIRMEV
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/apap 500
Oxycodone 5/apap 500
p-(Acetylamino)phenol
Paceco
Pacemo
Pacemol
Pacet
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine co
Panadiene
PANADO
Panado-co
Panado-co caplets
Panadol
PANADOL ACTIFAST
PANADOL ACTIFAST SOLB
PANADOL ADVAN
Panadol extra strength
PANADOL JNR
Panadol junior strength caplets
Panadol maximum strength caplets
Panadol maximum strength tablets
PANADOL OA
Panaleve
PANALEVE 6 PLUS
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-deine #3
Papa-deine #4
Paracemol
Paracenol
Paracet
Paracetamol
PARACÉTAMOL
Paracetamol al
Paracetamol antipanin p
Paracetamol basics
Paracetamol BC
Paracetamol DC
Paracetamol dr. schmidgall
Paracetamol fecofar
Paracetamol genericon
Paracetamol hanseler
Paracetamol harkley
Paracetamol heumann
Paracetamol hexal
Paracetamol italfarmaco
Paracetamol nycomed
Paracetamol PB
Paracetamol raffo
Paracetamol ratiopharm
Paracetamol rosch
Paracetamol saar
Paracetamol smithkline beecham
Paracetamol stada
Paracetamol von CT
Paracetamol winthrop
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
PARAMIN
Paramol
Paramolan
Paranox
PARAPAED JNR
PARAPAED SIX PLUS
Parapan
Parasedol
Parasin
Paraspen
Para-suppo
Para-tabs
PARAVICT
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
PCM Paracetamol lichtenstein
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-demi
Percogesic with codeine
Perdolan mono
PERFALGAN
Pe-tam
Phenaphen
Phenaphen caplets
Phenaphen w/codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin forte
P-HYDROXY-ACETANILID
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
Pinex
Piramin
Pirinasol
PLACIDEX
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet world
Redutemp
Reliv
Remedol
Rhinex D-lay tablets
RIMADOL
Rivalgyl
Robigesic
Robitussin night relief
Rockamol plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sinedol
Sine-OFF sinus medicine caplets
Sinmol
Sinubid
SK-Apap
Snaplets-FR
Spalt fur die nacht
Spalt N
ST Joseph aspirin-free
ST Joseph aspirin-free for children
St. joseph cold tablets for children
St. joseph fever reducer
Stanback
Stopain
Sudafed severe cold formula
Sudafed sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-m
Synalgos-DC-a
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol extra strength caplets
Tapanol extra strength tablets
Tapar
Tavist allergy/sinus/headache
Tazamol
Temlo
Tempanal
Tempra
Tempra caplets
Tempra chewable tablets
Tempra d.s
Tempra drops
Tempra syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
TIXYMOL
Tizide
Tocris-1706
Toximer p
Tralgon
TRAMIL 500
Treupel mon
Treupel N
Treuphadol
Triad
Triaminic sore throat formula
Triaprin
Tricoton
Tussapap
Tycolet
TYL
Tylenol
Tylenol allergy sinus
Tylenol arthritis extended relief
Tylenol caplets
Tylenol children's chewable tablets
Tylenol children's elixir
Tylenol children's suspension liquid
Tylenol drops
Tylenol elixir
Tylenol extra strength adult liquid pain reliever
Tylenol extra strength caplets
Tylenol extra strength gelcaps
Tylenol extra strength tablets
Tylenol gelcaps
Tylenol infants drops
Tylenol infants" suspension drops
Tylenol junior strength caplets
Tylenol junior strength chewable tablets
Tylenol regular strength caplets
Tylenol regular strength tablets
Tylenol tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor richet
Vicodin
Vicodin es
Vicodin HP
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
|
|
16 |
|
Tramadol |
Approved, Investigational |
Phase 4 |
|
27203-92-5 |
33741 5523 |
Synonyms:
(+)-Tramadol
(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol
(1RS,2RS)-2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)-CYCLO-HEXANOL
(1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol|Maxitram®|Tilodol®|Tramacet®
1a Brand OF tramadol hydrochloride
AbZ brand OF tramadol hydrochloride
Acis brand OF tramadol hydrochloride
Adolonta
Aliud brand OF tramadol hydrochloride
Allphar brand OF tramadol hydrochloride
Alpharma brand OF tramadol hydrochloride
Amadol
Amanda
Antigen brand OF tramadol hydrochloride
ASTA medica brand OF tramadol hydrochloride
Azupharma brand OF tramadol hydrochloride
Basics brand OF tramadol hydrochloride
Bayvit brand OF tramadol hydrochloride
Betapharm brand OF tramadol hydrochloride
Bexal brand OF tramadol hydrochloride
Biocodex brand OF tramadol hydrochloride
Biodalgic
Biokanol
Byk brand OF tramadol hydrochloride
Christiaens brand OF tramadol hydrochloride
Ciclum brand OF tramadol hydrochloride
Cinfa brand OF tramadol hydrochloride
Clonmel brand OF tramadol hydrochloride
Contramal
Crispin
CSL Brand OF tramadol hydrochloride
Docpharm brand OF tramadol hydrochloride
Dolorgiet brand OF tramadol hydrochloride
Edigen brand OF tramadol hydrochloride
Elerte brand OF tramadol hydrochloride
Erempharma brand OF tramadol hydrochloride
ETS6103
ETS-6103
Expanscience brand OF tramadol hydrochloride
Grunenthal brand OF tramadol hydrochloride
Hameln brand OF tramadol hydrochloride
Heumann brand OF tramadol hydrochloride
Hexal brand OF tramadol hydrochloride
Janssen brand OF tramadol hydrochloride
Juta brand OF tramadol hydrochloride
Jutadol
Kade brand OF tramadol hydrochloride
Kern brand OF tramadol hydrochloride
Knoll brand OF tramadol hydrochloride
Krewel brand OF tramadol hydrochloride
Lakeside brand OF tramadol hydrochloride
Lichtenstein brand OF tramadol hydrochloride
Lindopharm brand OF tramadol hydrochloride
Mabo brand OF tramadol hydrochloride
MAXITRAM
Medix brand OF tramadol hydrochloride
Merck dura brand OF tramadol hydrochloride
MTW Brand OF tramadol hydrochloride
MTW Tramadol
MTWTramadol
MTW-Tramadol
Mundipharma brand OF tramadol hydrochloride
Nobligan
Normon brand OF tramadol hydrochloride
Ortho brand OF tramadol hydrochloride
Prontofort
Q Pharm brand OF tramadol hydrochloride
Q-Pharm brand OF tramadol hydrochloride
Ralivia ER
Ralivia Flashtab
Ranitidin 1a pharma
Ratiopharm brand OF tramadol hydrochloride
Rowa brand OF tramadol hydrochloride
Searle brand OF tramadol hydrochloride
Stadapharm brand OF tramadol hydrochloride
TAD brand OF tramadol hydrochloride
|
Takadol
Theradol
Theraplix brand OF tramadol hydrochloride
TILODOL
Tiral
Topalgic
Tradol
Tradol puren
Tradol-puren
TradolPuren
Tradonal
Tralgiol
Trama 1a pharma
Trama abz
Trama dorsch
Trama KD
Tramabeta
TRAMACET
Tramadin
Tramadoc
Tramadol
Tramadol 1a
Tramadol acis
Tramadol al
Tramadol asta medica
Tramadol basics
Tramadol bayvit
Tramadol bexal
Tramadol cinfa
Tramadol dolgit
Tramadol edigen
Tramadol hameln
Tramadol HCl
Tramadol HCl BP/EP
Tramadol heumann
Tramadol hydrochloride
Tramadol kern
Tramadol lichtenstein
Tramadol lindo
Tramadol mabo
Tramadol normon
Tramadol PB
Tramadol ratiopharm
Tramadol stada
Tramadol viatris brand
Tramadol-dolgit
TramadolDolgit
Tramadol-hameln
TramadolHameln
Tramadolor
Tramadolratiopharm
Tramadol-ratiopharm
Tramadolum
Tramadolum [INN-Latin]
Trama-dorsch
TramaDorsch
Tramadura
Tramagetic
Tramagit
Tramake
Tramal
Tramex
Tramodol Hcl
Tramundin
Trasedal
Tridural
ULTRACET
Ultram
Ultram ER
Viatris brand OF tramadol
Xymel 50
Zambon brand OF tramadol hydrochloride
Zamudol
Zumalgic
Zydol
Zytram
|
|
17 |
|
Indomethacin |
Approved, Investigational |
Phase 4 |
|
53-86-1 |
3715 |
Synonyms:
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate
1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
Aconip
Amuno
Apo-Indomethacin
Argun
Arthrexin
ARTRACIN
ARTRACIN SR
Artrinovo
Artrivia
BERLIND 75 RET
Bonidin
Bonidon
Bonidon Gel
Catlep
Chibro-Amuno
Chrono-Indicid
Chrono-Indocid
Confortid
Dolcidium
Dolcidium Pl
Dolovin
Durametacin
Elmetacin
Flexin Continus
FLEXIN-25 CONTINUS
FLEXIN-50 CONTINUS
FLEXIN-75 CONTINUS
Hicin
Hydrochloride, indomethacin
Idomethine
IMBRILON
IMN
Inacid
Indacin
Indaflex
Indameth
Indmethacine
Indocid
Indocid Pda
INDOCID RET
Indocid Sr
Indocid®|Indocin®
INDOCID-R
Indocin
Indocin I.V
Indocin I.V.
INDOCIN SR
INDODERM
INDOFLEX
INDOLAR
INDOLAR SR
INDO-LEMMON
INDOMAX-25
INDOMAX-75 SR
Indomecol
|
Indomed
Indomee
Indomet 140
Indometacin
INDOMETACIN FARNESIL
Indometacina
Indometacine
Indometacinum
Indometacyna
INDOMETHACIN
Indomethacin hydrochloride
Indomethacine
Indomethacinum
Indomethancin
Indomethazine
Indomethegan
Indomethine
Indometicina
Indomo
INDOMOD
INDO-PAED
Indo-Phlogont
Indoptic
INDOPTOL
Indo-Rectolmin
Indorektal
Indo-Spray
Indo-Tablinen
INDOTARD MR 75
Indoxen
Inflazon
Infrocin
Inteban Sp
Lausit
LEDMECIN
Liometacen
MAXIMET SR
Metacen
Metartril
Methazine
Metindol
Miametan
Mikametan
MOBILAN
Novomethacin
Novo-Methacin
NSC-77541
Nu-Indo
Osmosin
PARDELPRIN MR
Reumacide
Rhemacin La
RHEUMACIN LA
RIMACID
Sadoreum
SLO-INDO
Tannex
TIVORBEX
Vonum
|
|
18 |
|
Esomeprazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
73590-58-6, 119141-88-7 |
9568614 4594 |
Synonyms:
( -)-Omeprazole
(−)-omeprazole
(-)-Omeprazole
(S)-(−)-omeprazole
(S)-(-)-Omeprazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
(S)-Omeprazole
(S)-omeprazole|Nexium®
2,3,5-Trimethylpyridine/Omeprazole
A02BC05
Alenia
Antra
Antra mups
AstraZeneca brand OF esomeprazole magnesium
Audazol
Aulcer
Axagon
Belmazol
Ceprandal
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
EMOZUL
Epirazole
Erbolin
Escz
Esofag
Esomeprazol
Esomeprazole
Ésoméprazole
Esomeprazole magnesium
Esomeprazole potassium
Esomeprazole sodium
Esomeprazole strontium
Esomeprazole strontium anhydrous
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168/68
H 168/68|Losec®|Prilosec®
H-168/68
Indurgan
Inexium paranova
Inhibitron
Inhipump
Lensor
Logastric
Lomac
Losec
LOSEC MUPS
Lucen
Magnesium, omeprazole
Mepral
MEZZOPRAM
Miol
Miracid
Mopral
Morecon
Nexiam
Nexium
NEXIUM CONTROL
NEXIUM I.V.
Nexium IV
Nilsec
Nopramin
|
Nuclosina
Ocid
Olexin
Omapren
Omebeta 20
Omed
Omegast
OMEP
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole magnesium
Omeprazole pellets
Omeprazole S-form
Omeprazole sodium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprol
OMERAN
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
OMP
Ompanyt
OMZ
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick_808
Prilosec
Prilosec otc
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
Sanamidol
Secrepina
Sodium, omeprazole
Strontium, esomeprazole
Tedec ulceral
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
VENTRA
Victrix
ZANPROL
Zefxon
Zegerid
Zepral
Zimor
Zoltum
|
|
19 |
|
Ubidecarenone |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
303-98-0 |
5281915 |
Synonyms:
(all-e)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
(all-e)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-cyclohexadiene-1,4-dione
2-((all-e)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2,3-Dimethoxy-5-methyl-6-decaprenylbenzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-cyclohexadiene-1,4-dione
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone
4-Ethyl-5-fluoropyrimidine
Adelir
all-trans-Ubiquinone
API 31510
API-31510
Aqua Q 10l10
Aqua Q10
Bio-quinon
Bio-quinone Q10
Coenzyme Q10
Coenzyme Q-10
CO-Enzyme Q10
CoQ
CoQ 10
CoQ10
Ensorb
Kaneka Q10
|
Kudesan
Li-Q-sorb
Liquid-Q
Neuquinon
Neuquinone
NSC-140665
NSC-140865
PureSorb Q 40
Q
Q 10AA
Q 199
Q10
Q-Gel
Q-Gel 100
Q-Ter
Ubidecarenone
UBIDECARENONE FOR SYSTEM SUITABILITY
Ubiquinone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
UBIQUINONE-10
Unbiquinone
Unispheres Q 10
|
|
20 |
|
Natriuretic Peptide, Brain |
|
Phase 4 |
|
|
|
21 |
|
Heptavalent Pneumococcal Conjugate Vaccine |
|
Phase 4 |
|
|
|
22 |
|
Triamcinolone hexacetonide |
|
Phase 4 |
|
|
|
Synonyms:
ARISTOSPAN
CL-34433
LEDERSPAN
|
TATBA
TRIAMCINOLONE HEXACETONIDE
|
|
23 |
|
Triamcinolone diacetate |
|
Phase 4 |
|
|
|
Synonyms:
ARISTOCORT
KENACORT
ORION
POLCORTOLON
|
TEDAROL
TRIAMCINOLONE 16,21-DIACETATE
TRIAMCINOLONE DIACETATE
|
|
24 |
|
Triamcinolone Acetonide |
|
Phase 4 |
|
|
6436 |
Synonyms:
ADCORTYL
ADCORTYL IN ORABASE
ALLERNAZE
ARISTOCORT
ARISTOCORT A
ARISTOGEL
AUDICORT
AUREOCORT
AZMACORT
FLUTEX
GPPE EAR DPS CAP
GPPE EAR OINT
KENACORT
KENACOURT
KENALOG
KENALOG IN ORABASE
KENALOG-10
KENALOG-40
KENALOG-80
KENALOG-H
NASACORT
NASACORT ALLERGY 24 HOUR
NASACORT AQ
|
NASACORT HFA
NSC-21916
NYSTADERMAL
ORACORT
ORALONE
PEVARYL T.C.
REMIDERM
REMOTIC
SILDERM
TRIACET
TRIACORT
TRI-ADCORTYL
TRIAMCINOLONE ACETONIDE
TRIAMCINOLONE ACETONIDE IN ABSORBASE
TRIATEX
TRIDERM
TRIESENCE
TRI-NASAL
TRIVARIS
TRYMEX
VETALOG
ZILRETTA
Zilretta®
|
|
25 |
|
Antiprotozoal Agents |
|
Phase 4 |
|
|
|
26 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
27 |
|
Antimalarials |
|
Phase 4 |
|
|
|
28 |
|
Endothelial Growth Factors |
|
Phase 4 |
|
|
|
29 |
|
Mitogens |
|
Phase 4 |
|
|
|
30 |
|
Cholestyramine Resin |
|
Phase 4 |
|
|
|
31 |
|
Adrenergic alpha-Antagonists |
|
Phase 4 |
|
|
|
32 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
33 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
34 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
35 |
|
Anesthetics |
|
Phase 4 |
|
|
|
36 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
37 |
|
Tripterygium |
|
Phase 4 |
|
|
|
38 |
|
Tumor Necrosis Factor Inhibitors |
|
Phase 4 |
|
|
|
39 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
40 |
|
Immune Checkpoint Inhibitors |
|
Phase 4 |
|
|
|
41 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
42 |
|
Angiogenesis Inhibitors |
|
Phase 4 |
|
|
|
43 |
|
Ubiquinone |
|
Phase 4 |
|
|
|
44 |
|
Immunoglobulins |
|
Phase 4 |
|
|
|
45 |
|
Antibodies, Monoclonal |
|
Phase 4 |
|
|
|
46 |
|
Antibodies |
|
Phase 4 |
|
|
|
47 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
48 |
|
Cyclooxygenase 2 Inhibitors |
|
Phase 4 |
|
|
|
49 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
50 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 540)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy and Safety of Etanercept Dose Reduction in Patients With Ankylosing Spondylitis |
Unknown status |
NCT02638896 |
Phase 4 |
etanercept (Half-Dose);etanercept (Full-Dose);Sulfasalazine;Celecoxib |
2 |
Can New Imaging- and Bio-markers Improve the Assessment of Disease Activity and Progression and Predict Therapeutic Outcome in Spondyloarthritis Patients Receiving Adalimumab |
Unknown status |
NCT00477893 |
Phase 4 |
Adalimumab;Placebo |
3 |
Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs, a Prospective Randomized Controlled Study |
Unknown status |
NCT04077957 |
Phase 4 |
Methotrexate;Sulfasalazine;Hydroxychloroquine;Etanercept (50mg per week, for 4 weeks);Etanercept (50mg per week, for 2 weeks);Etanercept (50mg per week) |
4 |
The Efficacy of Adalimumab and Conventional Antirheumatic Drugs in Alleviating Axial and Aortic Inflammation Detected in PET/CT in Patients With Axial Spondyloarthritis |
Unknown status |
NCT02634541 |
Phase 4 |
Adalimumab |
5 |
Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis |
Unknown status |
NCT02132234 |
Phase 4 |
Etanercept;Adalimumab;Certolizumab;Infliximab |
6 |
Prospective Evaluation of Heart Function by Echocardiographic Study, Pro-brain Natriuretic Peptide Type B and Troponin T in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker |
Unknown status |
NCT01072058 |
Phase 4 |
TNF blockers (infliximab, adalimumab, etanercept) |
7 |
Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study |
Unknown status |
NCT02489760 |
Phase 4 |
|
8 |
TReat-to-tArget (T2T) With seCukinumab in Axial Spondyloarthritis. IdEntification of MRI and Biochemical Biomarkers for Disease Activity, Treatment Response and Structural Damage Progression (the TRACE Study) |
Unknown status |
NCT03639740 |
Phase 4 |
Secukinumab 150 milligram [Cosentyx] |
9 |
A Multicenter,Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis |
Unknown status |
NCT03932006 |
Phase 4 |
Fengshigutong Capsule plus Imrecoxib;Fengshigutong Capsule;Imrecoxib |
10 |
Risk of Tuberculosis and Infections in Spondyloarthritis Patients Treated With Tofacitinib in Bangladesh |
Unknown status |
NCT03504072 |
Phase 4 |
Tofacitinib 5 mg,;Etanercept |
11 |
A Phase-IV, Multicenter, Noncomparative, Open-Label Study Evaluating the Safety and Efficacy of Golimumab (a Fully Human Anti-TNFα Monoclonal Antibody, Administered Subcutaneously) in the Treatment of Indian Patients With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis |
Completed |
NCT03733925 |
Phase 4 |
Golimumab |
12 |
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Randomized Controlled Trial |
Completed |
NCT01718951 |
Phase 4 |
golimumab;Pamidronate |
13 |
A Prospective Study of the Use of the Madrid Ultrasound Scoring System in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis |
Completed |
NCT02960035 |
Phase 4 |
50mg etanercept;25mg etanercept;placebo |
14 |
TNFalfa Blocking Treatment of Spondylarthropathies - A Danish Multicenter Study of New Methods for Better Monitoring and Prognostifying Patients With Spondylarthropathies |
Completed |
NCT00133315 |
Phase 4 |
Infliximab;Etanercept;Adalimumab |
15 |
Evaluation of Clinical Value of Standardized Protocol for Dose-reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF Therapy: Open-label, Controlled, Randomized, Multicenter Trial. |
Completed |
NCT01604629 |
Phase 4 |
Reduced doses of anti-TNF;Stable doses of anti-TNF |
16 |
A Multicentre, Double-Blind, Placebo-Controlled, Randomized Study of Etanercept in the Treatment of Adults Patients With Refractory Heel Enthesitis in Spondylarthropathy |
Completed |
NCT00420303 |
Phase 4 |
Etanercept |
17 |
Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis Results From MRI Finding |
Completed |
NCT03190603 |
Phase 4 |
Celecoxib |
18 |
Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar® |
Completed |
NCT00828997 |
Phase 4 |
|
19 |
Efficacy and Safety of Loxoprofen Hydrogel Patch Versus Loxoprofen Tablet in Patients With Ankylosing Spondylitis: a 4-week Randomized, Open-label Study |
Completed |
NCT03800797 |
Phase 4 |
Loxoprofen sodium hydrogel patch;Loxoprofen sodium tablet |
20 |
Baseline Serum Vascular Endothelial Growth Factor (VEGF) Concentration as Predictive Factor of Response to Infliximab (Remicade) Therapy in Patients With Active Ankylosing Spondylitis Despite Conventional Treatment: a Multicenter Pilot Study |
Completed |
NCT00779935 |
Phase 4 |
|
21 |
Multicenter, Open-Label Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis Flares in Axial Spondyloarthritis Subjects With a History of Anterior Uveitis (C-VIEW) |
Completed |
NCT03020992 |
Phase 4 |
Certolizumab Pegol |
22 |
Whole Human Genome Oligo Microarray Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment Compared to Healthy Controls |
Completed |
NCT00778869 |
Phase 4 |
|
23 |
Effects of NSAIDs on RAdiographic Damage in Ankylosing Spondylitis (ENRADAS) - a Prospective Randomised Controlled Trial |
Completed |
NCT00715091 |
Phase 4 |
diclophenac |
24 |
Effect of Methotrexate on the Relation Dose-effect of Infliximab in Ankylosing Spondylitis |
Completed |
NCT00507403 |
Phase 4 |
infliximab |
25 |
Multicentre, Open-Labeled Study Of Etanercept In The Treatment Of Patients With Ankylosing Spondylitis |
Completed |
NCT00458185 |
Phase 4 |
etanercept |
26 |
An Open-Label Multicentre Long-Term Extension Study of Etanercept in Ankylosing Spondylitis |
Completed |
NCT00444340 |
Phase 4 |
Enbrel (Etanercept) |
27 |
Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) |
Completed |
NCT01895764 |
Phase 4 |
Adalimumab;Methotrexate |
28 |
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease. Impact of Antirheumatic Treatment on Antibody Response. |
Completed |
NCT03762824 |
Phase 4 |
|
29 |
COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of StrUctural Damage in the Spine Over Two Years in Patients With ankyLosing Spondylitis: a Randomized Controlled Multicentre Trial |
Completed |
NCT02758782 |
Phase 4 |
Celecoxib |
30 |
Post-Registration Open-Label, Non-Comparative, Multicenter Study of Rate of Efficacy and Tolerance of the Use of Anti-TNF Chimeric Monoclonal Antibodies (Remicade) in Treatment of Patients With Active Ankylosing Spondylitis |
Completed |
NCT00779012 |
Phase 4 |
|
31 |
The Efficacy of Combination Methotrexate and Infliximab in Patients With Ankylosing Spondylitis:A Clinical and Magnetic Resonance Imaging Correlation |
Completed |
NCT00432432 |
Phase 4 |
Infliximab and MTX |
32 |
Chung Shan Medical University Hospital, Taiwan |
Completed |
NCT00647517 |
Phase 4 |
Ultracet |
33 |
A Randomized, Double-blind, Parallel-group, Multicenter Study of Secukinumab to Compare 300 mg and 150 mg at Week 52 in Patients With Ankylosing Spondylitis Who Are Randomized to Dose Escalation After Not Achieving Inactive Disease During an Initial 16 Weeks of Open-label Treatment With Secukinumab 150 mg (ASLeap) |
Completed |
NCT03350815 |
Phase 4 |
150 mg open-label secukinumab;150 mg double-blinded secukinumab;300 mg double-blinded secukinumab |
34 |
A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the NSAID-sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis (ASTRUM) |
Completed |
NCT02763046 |
Phase 4 |
Secukinumab (AIN457) 150 mg s.c.;Placebo - Secukinumab (AIN457) 150 mg s.c. |
35 |
A Multicentre, Double-Blind, Placebo-Controlled, Randomised Study of Etanercept in the Treatment of Adult Patients With Active, Severe, and Advanced Axial Ankylosing Spondylitis |
Completed |
NCT00420238 |
Phase 4 |
Etanercept (Enbrel) |
36 |
An Open-label, Multicentre, Supplementary Extension Study of Etanercept in Subjects With Ankylosing Spondylitis |
Completed |
NCT00410046 |
Phase 4 |
Enbrel (etanercept) |
37 |
A Multi-center, Open Label, Random Clinical Trial of Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis |
Completed |
NCT01934933 |
Phase 4 |
celebrex;Enbrel;Enbrel plus Celebrex |
38 |
Ultrasound Guided Epidural Block in Axial SPA Patient With Limited Spine Mobility: a Prospective Pilot Randomized Controlled Trial |
Completed |
NCT04143165 |
Phase 4 |
Epidural block with lidocaine and triamcinilone |
39 |
A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SWITCHING FROM INNOVATOR INFLIXIMAB TO BIOSIMILAR INFLIXIMAB COMPARED WITH CONTINUED TREATMENT WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, ULCERATIVE COLITIS, CROHN'S DISEASE AND CHRONIC PLAQUE PSORIASIS THE NOR-SWITCH STUDY |
Completed |
NCT02148640 |
Phase 4 |
Innovator infliximab;Biosimilar infliximab |
40 |
A 12-week Randomized, Double-blind, Multicenter Pilot Study to Evaluate the Effect of Etanercept 100 mg and 50 mg Weekly in Subjects With Ankylosing Spondylitis |
Completed |
NCT00873730 |
Phase 4 |
etanercept;etanercept/placebo |
41 |
A Phase-IV, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of Golimumab (MK-8259 [SCH 900259]) After Treatment Withdrawal, Compared With Continued Treatment (Either Full- or Reduced-Treatment Regimen), In Subjects With Non-Radiographic Axial Spondyloarthritis |
Completed |
NCT03253796 |
Phase 4 |
|
42 |
Biomarkers Identification of Anti-TNF α Agent's Efficacy in Ankylosing Spondylitis Patients Using a Transcriptome Analysis and Mass Spectrometry |
Completed |
NCT02492217 |
Phase 4 |
Adalimumab |
43 |
Treatment of Active Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor â…¡ IgG Fc Fusion Protein Injection: a Randomized, Double-blind, Multicentral Clinical Trial to Investigate the Efficacy and Safety of Yisaipu® |
Completed |
NCT02364479 |
Phase 4 |
50mg Yisaipu;25mg etanercept;Placebo |
44 |
Effect of Continuous Administration of Different Therapeutic Dosages of Indomethacin and Etoricoxib in the Management of Axial Spondyloarthritis: A Randomized Controlled Trial |
Completed |
NCT03582332 |
Phase 4 |
Indomethacin SR, 75 Mg Oral Capsule, Extended Release;Indomethacin 25 Mg Oral Capsule;Etoricoxib 90 mg;Etoricoxib 60 mg |
45 |
A Clinical Trial About the Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis: a 12-week, Multi-center, Randomized, Double-blind, Active Drug and Placebo Compared Clinical Trial |
Completed |
NCT00953979 |
Phase 4 |
kunxian capsule |
46 |
A Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Etanercept and Sulphasalazine in Subjects With Ankylosing Spondylitis |
Completed |
NCT00247962 |
Phase 4 |
etanercept;sulphasalazine (SSZ) |
47 |
Open-Label, Phase 4 Study, Investigating the Incidence of Extra-Articular Manifestations in Subjects With Ankylosing Spondylitis Treated With Golimumab; Protocol No. MK-8259-012 |
Completed |
NCT01668004 |
Phase 4 |
|
48 |
An Open Trial to Evaluate the Efficacy and Safety of Infliximab(Remicade) in Treating Patients With Early Ankylosing Spondylitis |
Completed |
NCT00936143 |
Phase 4 |
infliximab |
49 |
Sequential Application of Yisaipu® and Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Treating Mild-to-Moderate Ankylosing Spondylitis: the Mid-term Follow-up Result |
Completed |
NCT03411798 |
Phase 4 |
Yisaipu® |
50 |
A Twelve Week, Randomized, Double Blind Parallel Group Study Of Two Doses Of Celecoxib Compared To Diclofenac In Patients With Ankylosing Spondylitis |
Completed |
NCT02528201 |
Phase 4 |
Celecoxib 200 milligrams;Celecoxib 400 milligrams;diclofenac 50 milligrams |
|